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Human papillomavirus (HPV) infection is severely limited in its natural host, primary human
keratinocytes. Our data show HPV infectivity in primary keratinocytes is over 100- and 1,000-fold
lower than in established keratinocyte cell lines NIKS and HaCaT, respectively. Here, we show that the
basal level of autophagy in primary human foreskin keratinocytes (HFKs) is higher than in immorta-
lized keratinocytes, and that HPV16 virions signiﬁcantly induce autophagy in HFKs. Interestingly,
HPV16 infectivity is dramatically enhanced by knockdown of essential autophagy genes as well as
biochemical inhibition of autophagy. The increase in HPV16 infectivity by autophagy inhibition is most
signiﬁcant in HFKs, showing an inverse correlation with basal HPV16 infectivity in HFK, NIKS, HaCaT,
and 293FT cells. Further, inhibition of autophagy delays degradation of HPV16 capsid proteins during
virus trafﬁcking, indicating that host autophagy induced by HPV16 virions inhibits infection of primary
keratinocytes through rapid degradation of viral capsid proteins.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human papillomaviruses (HPVs) are small non-enveloped
double-stranded DNA viruses that strictly infect mucosal and
cutaneous epithelia. HPVs are causally associated with multiple
human cancers including 499% of cervical cancers, 50% of
other anogenital cancers, and 25% of head and neck cancers (zur
Hausen, 1996, 1999; Gillison and Shah, 2001; Burd, 2003; Gillison
and Lowy, 2004). HPV-associated cancers account for about half a
million deaths worldwide every year, with cervical cancer being
the third leading cause of cancer deaths in women (zur Hausen,
1996, 1999; Burd, 2003). Over 100 genotypes of HPVs have been
identiﬁed and categorized by oncogenicity, with HPV16 being the
most prevalent genotype found in HPV-associated cancers (Burd,
2003).
HPV genomic DNA is encased by a 55 nm icosahedral capsid,
which is comprised of the major capsid protein, L1, and the minor
capsid protein, L2 (Modis et al., 2002). Virions initially bind to
the basement membrane of the mucosal epithelium throughll rights reserved.
ology, University of
ted States.
yeon).interactions between L1 and heparan sulfate proteoglycans
(HSPGs), triggering conformational changes in both L1 and L2
capsid proteins (Joyce et al., 1999; Giroglou et al., 2001; Selinka
et al., 2003; Yang et al., 2003). Subsequent steps in infectious
entry remain poorly understood, as more speciﬁc interactions
necessary to confer the strict tropism to basal keratinocytes have
not yet been deﬁned.
Several conﬂicting results regarding the internalization and
subsequent endocytic trafﬁcking of HPV virions during entry have
been reported. Previously, multiple studies showed that HPV16
internalization is blocked by biochemical inhibition of clathrin
and dynamin-2, suggesting that HPV16 entry requires clathrin-
dependent endocytosis (Bousarghin et al., 2003; Day et al., 2003;
Abban et al., 2008; Laniosz et al., 2009). However, recent studies
using genetic knockdowns and dominant negative mutants
showed that HPV16 internalization is independent of clathrin,
dynamin, caveolin, and lipid rafts (Spoden et al., 2008; Schelhaas
et al., 2012). These studies also suggested that HPV16 entry
requires tetraspanin-enriched microdomains and endocytosis
similar to, but distinct from, classical macropinocytosis (Spoden
et al., 2008; Schelhaas et al., 2012). These discrepancies may be
attributed to the different cell culture models used in these
studies. For example, some of the experiments that showed a
clathrin-dependent mechanism of HPV16 entry were conducted
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2008), whereas the more recent experiments showing a clathrin-
independent mechanism of HPV16 entry were carried out in HeLa
and HaCaT cells (Spoden et al., 2008; Schelhaas et al., 2012). Even
among different keratinocytes, we have observed signiﬁcant
differences in HPV16 infectivity (Fig. 1A), indicating that the
mechanisms of HPV16 entry may differ depending on the cell
culture model used to study it.
One point of consensus, however, is that all HPVs require low
pH for infectious entry, as they must pass through acidiﬁed
compartments (i.e. late endosomes, lysosomes), where it is
thought that viral DNA uncoating and egress from the endosomal
pathway occurs (Selinka et al., 2002; Day et al., 2003; Ka¨mper
et al., 2006; Abban et al., 2008; Smith et al., 2008; Spoden et al.,
2008). Interestingly, a recent study showed that HPV16 virions
colocalize with Rab5-containing compartments, but not with
other markers of early endosomes, indicating trafﬁcking to
acidiﬁed vesicles via alternate Rab5-containing vesicles
(Schelhaas et al., 2012). Rab5 plays critical roles in the biogenesis
and coordination of early endosomes as well as autophagosomes,
suggesting that virions may transit through autophagosomes
during entry (Zerial et al., 1999a; Zerial et al., 1999b; Ravikumar
et al., 2008). Autophagy has essential functions in cell home-
ostasis, as autophagosomes engulf bulk cytoplasm, including
damaged organelles, and shuttle them to lysosomes for degrada-
tion and recycling of nutrients (reviewed in Levine and Kroemer,
2008). Recent studies demonstrated that autophagy also has
signiﬁcant roles in host defense including detection, degradation,
and antigen presentation of several intracellular pathogens
(reviewed in Levine and Kroemer, 2008; Kudchodkar and
Levine, 2009; Mack and Mu¨nger, 2012). Interestingly, Rab5 is
required for induction of autophagy by Hepatitis C Virus (Su et al.,
2011).
Here, we show a role of host autophagy in HPV16 entry into its
natural host, primary human keratinocytes. HPV16 infectivity in
primary keratinocytes was signiﬁcantly enhanced by inhibition of
autophagy using 3-methyladenine (3-MA), as well as shRNA-
mediated knockdown of essential autophagy genes, PIK3C3 and
ATG7. Interestingly, autophagy inhibition by 3-MA increased
HPV16 infectivity more dramatically in primary keratinocytes
with high levels of basal autophagy compared to immortalized
keratinocytes with low levels of autophagy, showing an inverse
correlation with basal HPV16 infectivity. Furthermore, using the
autophagosome marker, LC3, we found that HPV16 virions induce
host autophagy several hours post inoculation. Degradation ofFig. 1. Primary keratinocytes show limited HPV16 infectivity and high levels of bas
HPV16-LucF and incubated for 48 h. HPV16 infectivity and cell viability were measured
Cell Vi ability Assay (Promega), respectively. Infectivity data normalized to cell viabi
samples. The data shown here are from one representative of three independent experi
Pepstatin A (10 mg/mL each) or DMSO for 6 h, and harvested for immunoblotting of LC3,
of three independent experiments.HPV16 capsid proteins was also delayed by 3-MA mediated
autophagy inhibition during entry. Our results suggest that host
autophagy is induced by HPV16 virions as a host defense
mechanism to inhibit infection by facilitating degradation of
incoming virions.Results
HPV16 infectivity is limited in natural host primary keratinocytes
coincident with high levels of basal autophagy
As the natural host for HPV infection, primary human kerati-
nocytes have been accepted as one of the most relevant in vitro
cell culture models of HPV infection. However, HPV infection of
these cells is known to be particularly difﬁcult compared to
immortalized and transformed keratinocytes (Meyers et al.,
1997; Ozbun, 2002; Day et al., 2008). To directly compare the
differences in HPV16 infectivity among cell culture models
commonly used to study HPV entry and infection, we infected
primary human foreskin keratinocytes (HFK), two spontaneously
immortalized keratinocyte cell lines, NIKS and HaCaT, and the
human embryonic kidney cell line, 293FT, with HPV16 pseudo-
virions containing a luciferase reporter gene (HPV16-LucF).
At 48 h post infection (hpi), HPV infectivity was measured by
relative luciferase activity (Pyeon et al., 2009). We found that,
whileHPV infectivity is very limited in HFKs, it is well over
100-, 1,000-, and 100,000-folds greater in NIKS, HaCaT, and
293FT cells, respectively (Fig. 1A). Notably, HPV16 infectivity was
signiﬁcantly increased in NIKS cells compared to HFKs (400-
fold increase). Interestingly, of all cell culture models tested, HFK
and NIKS cells are most similar to one another in that both are
considered normal, near diploid keratinocytes that support nor-
mal differentiation programs.
The observed limited infectivity in HFKs could potentially be
explained by the previously reported lack of furin and L2 cleavage
of basement membrane-bound HPV16 virions (Day et al., 2008),
as well as differences in cell proliferation between cell lines
(Pyeon et al., 2009). We hypothesized that host autophagy could
be an additional restriction factor against HPV infection that
contributes to the low infectivity in primary keratinocytes.
Autophagy is a host defense mechanism against infection, directly
destroying intracellular pathogens and inducing innate immune
responses (reviewed in Levine and Kroemer, 2008; Kudchodkar
and Levine, 2009; Mack and Mu¨nger, 2012). To determine theal autophagy. (A) The indicated cell lines were inoculated with 10,000 vge/cell of
by Bright-GloTM Luciferase Assay System (Promega)and CellTiter-Glo Luminescent
lity are shown as average relative luminescence units (RLU) from quadruplicate
ments. (B) HFK and NIKS cells were treated with the protease inhibitors E64d and
using Actin as an internal control.The data shown here are from one representative
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protein levels of the established autophagosome marker, LC3
(Fig. 1B). LC3 is constitutively expressed in its soluble form,
LC3-I, and upon autophagy induction is lipidated to form LC3-II
(Kabeya et al., 2000, 2004). LC3-II stably associates with autop-
hagosome membranes, but is also a substrate for autophagic
protein degradation in autolysosomes following autophagosome-
lysosome fusion (Tanida et al., 2005). As a standard procedure to
prevent outﬂux of LC3-II in the autolysosome, we cultured cells
with the protease inhibitors E64d and Pepstatin A. Immunoblot-
ting of LC3 showed higher levels of autophagy in HFKs compared
with NIKS cells (Fig. 1B). This ﬁnding implies that autophagy may
restrict HPV16 infection in primary keratinocytes.HPV16 virions induce host autophagy in primary keratinocytes
Many intracellular pathogens have been shown to induce
autophagy as a host defense mechanism to sequester and deliver
them to the lysosome for degradation (reviewed in Levine and
Kroemer, 2008; Kudchodkar and Levine, 2009). To determine
whether HPV16 virions induce autophagy in primary keratino-
cytes, GFP-LC3 expressing HFKs were established and infected
with HPV16 virions containing the full-length HPV16 W12 gen-
ome (HPV16-W12) for 6 h (Flores et al., 1999). GFP puncta
represent autophagosome membrane-bound LC3-II distinct from
soluble LC3-I shown as diffuse GFP staining (Kabeya et al., 2000;
Mizushima, 2004). The GFP-LC3 puncta were visualized using
confocal microscopy (representative images shown in Fig. 2A) and
the number of puncta in each cell were counted using NIH ImageJ
in a blinded manner. To avoid potential artifacts from incubating
the cells with excess virions, 10-fold fewer virions were used in
these assays than for infectivity experiments. Interestingly, HFKsFig. 2. HPV16 virions induce host autophagy in primary keratinocytes. (A) HFKs
1,000 vge/cell of HPV16-W12, and incubated for 6 h. Cells were ﬁxed with 4% parafo
Technologies). At least 25 cells were imaged for each condition. Representative images
were counted using NIH ImageJ image analysis software and plotted to show the nu
(ANOVA) statistical analysis to determine the p-value was performed using GraphP
representative of two independent experiments. (C) HFKs were incubated with Krebs–R
for 6 h. LC3 and Actin were detected by immunoblotting. The data shown here are froincubated with HPV16-W12 showed signiﬁcantly increased num-
bers of GFP-LC3 puncta per cell (Fig. 2A and B). We further
validated our ﬁnding by detecting endogenous LC3 in HFKs
infected with HPV16-W12. At 6 hpi, we observed a signiﬁcant
increase in LC3-II, indicating that HPV16 virions induced autop-
hagy in HFKs. This increase in LC3-II by HPV16-W12 was
comparable in magnitude to the increase observed by starvation
conditions, one of the most potent means for inducing autophagy
(Fig. 2C). These results indicate that autophagy is induced by
HPV16 virions during entry into primary keratinocytes.Inhibition of autophagy by 3-MA signiﬁcantly enhances HPV16
infectivity of primary keratinocytes
To determine whether autophagy inhibits HPV16 infection in
primary keratinocytes, we tested the effect of the established
autophagy inhibitor 3-MA on HPV16 infectivity in HFKs. 3-MA is
an inhibitor of class III phosphatidylinositol-3 kinase (PIK3C3),
which plays an essential role in autophagosome formation
(Seglen and Gordon, 1982; Blommaart et al., 1997; Petiot et al.,
2000). We found that 3-MA treatment enhanced HPV16 infectiv-
ity in a dose-dependent manner up to almost 40-fold in HFKs
(Fig. 3A). The increased HPV16 infectivity by 3-MA corresponded
to decreased levels of autophagy, as measured by LC3 immuno-
blotting of cells treated with E64d and Pepstatin A (Fig. 3B). The
magnitude of autophagy inhibition by 3-MA was consistent with
previous reports (Seglen and Gordon, 1982; Fuertes et al., 2003;
Kawai et al., 2006). To determine whether the effect of autophagy
inhibition on HPV16 infectivity is unique to primary keratino-
cytes, we tested the effect of 3-MA on HPV16 infectivity in NIKS,
HaCaT, and 293FT cells in addition to HFKs. Interestingly, the
increase in HPV16 infectivity by 3-MA was most signiﬁcant inwere transduced with GFP-LC3-containing lentiviruses for 48 h, inoculated with
rmaldehyde and mounted with ProLongs Gold Antifade Reagent with DAPI (Life
are shown. (B) Quantiﬁcation of GFP-LC3 puncta obtained in (A). GFP-LC3 puncta
mber of GFP-LC3 puncta per cell. One-way analysis of variance between groups
ad Prism software (GraphPad Software, La Jolla, CA). Data shown are from one
inger Bicarbonate buffer for starvation condition, or 1,000 vge/cell of HPV16-W12
m one representative of three independent experiments.
Fig. 3. Inhibition of autophagy by 3-MA signiﬁcantly enhances HPV16 infectivity in primary keratinocytes. (A) Following pretreatment with the indicated
concentrations of 3-MA or vehicle for 4 h, HFKs were inoculatedwith 10,000 vge/cell of HPV16-LucF and incubated for 48 h in the presence of 3-MA or vehicle. Infectivity
and cell viability were measured as described above. Normalized infectivity data are presented as fold change in infectivity by 3-MA over vehicle control, and were
averaged from quadruplicate samples. (B) HFKs were treated with 6 mM 3-MA or vehicle for 6 h with protease inhibitors E64d and Pepstatin A (10 mg/mL each) or DMSO,
and harvested for immunoblotting of LC3 and Actin. (C) The indicated cell lines were treated with 6 mM 3-MA or vehicle, and inoculated with HPV16-LucF as in (A).
Normalized infectivity data are shown as fold changein infectivity by 3-MA over vehicle control. (D) The indicated cell lines were treated with 8 U/mL furin or vehicle, and
inoculated with HPV16-LucF as in (A). Normalized infectivity data are shown as fold change in infectivity by furin over vehicle control. The data shown here are from one
representative of three independent experiments. Student’s t-test was performed to determine p-values between 3-MA treatments and vehicle control using StatPluss
(AnalystSoft, Inc.).
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untreated cells presented in Fig. 1A (Fig. 3C). We also tested the
effect of furin cleavage on HPV16-LucF infectivity of human
keratinocytes by infecting the cells in the presence or absence
of exogenous furin. Consistent with the previous report (Day
et al., 2008), we observed an increase in infectivity by treatment
with furin, which was most dramatic in HFKs (8.5-fold increase)
compared to NIKS and HaCaT cells (Fig. 3D). These results suggest
that while the lack of furin cleavage of L2 signiﬁcantly limits
HPV16 infection of HFKs, high levels of host autophagy may be a
critical restriction factor that further contributes to the low basal
infectivity of primary keratinocytes.
To conﬁrm that 3-MA does not directly increase reporter
gene expression, we examined the effect of 3-MA in 293FT cells
transfected with the luciferase reporter plasmid (pLucF) compared
to 293FT cells infected with HPV16-LucF. 293FT cells were used in
this assay due to the low transfection efﬁciency of keratinocytes.
3-MA did not affect luciferase activity in the pLucF-transfected
cells, whereas it signiﬁcantly enhanced luciferase activity in
HPV16-LucF-infected cells (Fig. S1). This result conﬁrms that the
enhancement of HPV16 infectivity by 3-MA is speciﬁc to virus
infection and is not caused by directly altering reporter gene
expression.
To determine whether the enhancement of HPV16 infectivity
by 3-MA could be extended to low MOI infections, we tested the
effect of 3-MA on HPV16 infectivity with decreasing viral genome
equivalents (vge) of HPV16-LucF in HaCaT cells. HaCaT cells were
used in this assay, as low MOI infections are easily detectable in
HaCaT cells, allowing for more reliable infection assays. The result
showed that 3-MA enhanced HPV16 infectivity by approximately3 to 4 fold regardless of MOI (Fig. S2 and Fig. 3C). Furthermore, by
approximating the percentage of infected cells using a GFP
reporter, we estimate that the MOI of infection for HFKs using
10,000 vge/cell is approximately 0.02. These results indicate that
autophagy inhibition by 3-MA enhances HPV16 infection regard-
less of the amount of virus used.
Knockdown of essential autophagy genes PIK3C3 and ATG7 enhances
HPV16 infectivity of keratinocytes
To determine whether genetic knockdown of PIK3C3, the
target of 3-MA, enhances HPV16 infectivity, we generated HFKs
expressing shRNA against PIK3C3 (shR-PIK3C3) by lentiviral
delivery, followed by puromycin selection for 4 days to avoid
any potential artifacts due to coinfection of lentivirus and HPV.
HPV16-LucF infection was slightly increased by PIK3C3 knock-
down in HFKs (data not shown). However, this increase in HPV16
infectivity was not statistically signiﬁcant, which may be attrib-
uted to the cellular toxicity of the shR-PIK3C3 expression in HFKs,
indicated by their signiﬁcantly altered morphology and decreased
growth rate. Constitutive knockdown of PIK3C3 for more than one
week was toxic for primary keratinocytes. Thus, as an alternative
approach, we established NIKS cell lines that stably express shR-
PIK3C3 by puromycin selection for 42 weeks. Using the stable
NIKS cell lines, which showed no detectable toxicity, we found
that HPV16 infectivity was signiﬁcantly enhanced 4-fold by
PIK3C3 knock down (Fig. 4A and B).
A recent report showed evidence of a Pik3c3-independent
autophagy pathway in mouse sensory neurons, and that Atg7 is
required for both Pik3c3-dependent and Pik3c3-independent
Fig. 4. HPV16 infectivity is increased by knockdown of PIK3C3. (A) NIKS cells
were transduced with lentiviruses containing shRNAs against PIK3C3 (shR-
PIK3C3) or a non-target control (shR-ctrl). At 48 h post transduction, the
transduced cells were selected by culture in medium containing 1.5 mg/mL of
puromycin for 2 weeks to establish stable semi-clonal cell lines. Puromycin-
selected cells were inoculated with 10,000 vge/cell of HPV16-LucF and incubated
for 48 h. Infectivity was measured and normalized to cell viability as described in
Fig. 1. Normalized infectivity data are shown as fold change in infectivity by shR-
PIK3C3 over shR-ctrl, and were averaged from quadruplicate samples. Statistical
analysis was performed as described in Fig. 3A. (B) In parallel to the infection
assay in (A), immunoblotting was performed with the puromycin-selected cells
using anti-PIK3C3 (Life Technologies) and anti-Actin antibodies. The data shown
here are from one representative of three independent experiments.
Fig. 5. HPV16 infectivity is increased by knockdown of the essential autophagy
gene ATG7. (A) HFKs were transduced with lentiviruses containing shRNAs
against ATG7 (shR-ATG7) or shR-ctrl and puromycin-selected as in Fig. 3A.
Infection assay and analysis of puromycin-selected cells was conducted as in
Fig. 3A, and data are shown as fold change in infectivity by shR-ATG7 over
shR-ctrl. Statistical analysis was performed as described in Fig. 3A. (B) In parallel
to the infection assay in (A), immunoblotting was performed using anti-ATG7
antibody (ProSci) and Actin. The data shown here are from one representative of
three independent experiments. *Non-speciﬁc band.
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essential and speciﬁc autophagy gene ATG7 on HPV16 infectivity
in primary keratinocytes, we tested HPV16 infectivity in HFKs
knocked down for expression of ATG7. Our results showed an
5-fold enhancement of HPV16 infectivity by ATG7 knockdown
(Fig. 5A and B), with minimal toxicity. Thus, our results consis-
tently indicate that autophagy inhibits HPV16 infection in primary
keratinocytes.
Inhibition of autophagy by 3-MA protects incoming virions from
degradation during entry into primary keratinocytes
Next, we investigated which steps of virus entry are modu-
lated by autophagy including virus attachment, internalization,
and capsid degradation. To determine whether autophagy inhibi-
tion by 3-MA affects virus attachment to the host cell surface,
HFKs were pretreated with 3-MA for 4 h, chilled at 4 1C and
incubated with HPV16-W12 for 1 h at 4 1C to allow virus binding
while preventing internalization. After washing off unbound virus
particles, we detected the L1 major capsid protein byimmunoblotting. Our results showed that 3-MA treatment did
not affect the amount of virus attached to host cells (Fig. 6A). To
examine whether autophagy inhibition by 3-MA affects virus
internalization, HFKs treated as above were transferred to 37 1C
to initiate internalization. At 1 and 2 hpi, the cells were treated
with trypsin to eliminate bound but non-internalized virus
particles and the L1 capsid protein was detected by immunoblot-
ting. Again, 3-MA treatment of HFKs resulted in no difference in
the amount of internalized virions (Fig. 6B).
To investigate the effect of autophagy inhibition by 3-MA on
capsid protein degradation during entry into HFKs, the HFKs
treated with 3-MA and inoculated with HPV16-W12 as described
above were further incubated at 37 1C for 2, 4, 6, and 12 h. By
immunoblotting with the anti-HPV16 L1 antibody (CAMVIR-1),
we analyzed commonly detected degradation products of the L1
capsid protein during HPV entry (Chen and Okayama, 1987;
Campos et al., 2012). Interestingly, 3-MA treatment delayed the
rate of L1 degradation, which is most apparent by the decrease in
the amount of the 22 kDa degradation product at 2 and 4 hpi as
well as the faint 12 kDa degradation product at 6 and 12 hpi
(Fig. 6C). These results indicate that host autophagy facilitates
HPV16 capsid protein degradation during virus entry into primary
keratinocytes.Discussion
Our study revealed that host autophagy inhibits HPV16 infec-
tion in its natural host cell, primary human keratinocytes, as
HPV16 infectivity was signiﬁcantly enhanced by treatment with
the autophagy inhibitor, 3-MA, as well as knockdown of essential
autophagy genes PIK3C3 and ATG7. Interestingly, 3-MA treatment
increased HPV16 infectivity most dramatically in primary kerati-
nocytes, where basal infectivity is much lower and autophagy
levels are higher than other established keratinocyte cell lines,
such as NIKS and HaCaT. These data indicate that the low level of
basal HPV16 infectivity in primary keratinocytes may be partly
due to the high levels of host autophagy in these cells, in addition
to other restriction factors such as the lack of furin
and extracellular matrix. Furthermore, we showed that HPV16
virions efﬁciently induce host autophagy and that inhibition of
autophagy by 3-MA delayed the degradation of L1 capsid proteins
during entry. Taken together, these results suggest that HPV16
virions induce host autophagy as a host defense mechanism in
primary keratinocytes, which inhibits HPV16 infection by rapidly
degrading incoming virions.
Several previous publications have shown conﬂicting results
regarding the mechanisms of HPV internalization and trafﬁcking
in host cells (Bousarghin et al., 2003; Day et al., 2003; Abban et al.,
2008; Spoden et al., 2008; Laniosz et al., 2009; Schelhaas et al.,
2012). One potential explanation is the use of different cell
culture models to study HPV entry, many of which include
immortalized and transformed cells not of keratinocyte origin
such as 293 and COS-7 cell lines (Bousarghin et al., 2003; Abban
et al., 2008). We found that autophagy inhibition by 3-MA
increased HPV16 infectivity in normal mouse epithelial cells,
but not in mouse ﬁbroblasts (data not shown). This result
indicates that those two mouse cell types may have different
host mechanisms that support or restrict HPV16 entry. In human
keratinocytes, the natural host for HPV16 infection, the increase
in HPV16 infectivity by 3-MA vary among different cell culture
models. These data highlight the importance of using appropriate
cell culture models to understand physiologically relevant
mechanisms of HPV infection. As no procedure exists to isolate
authentic HPV virions, studies of HPV entry have solely relied on
the use of in vitro-generated HPV virions either from transfected
Fig. 6. The autophagy inhibitor, 3-MA, delays degradation of HPV16 L1 capsid proteins during entry. (A) Effect of 3-MA on virus binding. HFKs were pretreated with
6 mM 3-MA for 4 h. Cells were chilled to 4 1C to inhibit endocytosis, inoculated with 10,000 vge/cell of HPV16-W12 and incubated with or without 3-MA for 1 h at 4 1C.
Unbound virions were washed out and cells were lysed directly to observe total bound virions, followed by immunoblotting of L1 capsid protein (CAMVIR-1, Abcam). (B)
Effect of 3-MA on virus internalization. Virus internalization was initiated by shifting cells treated as in (A) to 37 1C. At the indicated hours post infection (hpi), cells were
trypsinized prior to lysis to observe only internalized virions, followed by immunoblotting of L1 capsid protein. (C) Effect of 3-MA on capsid protein degradation during
entry. Experiment was conducted as in (A) and (B) except 3-MA was added only when cells were shifted to 37 1C to initiate internalization (no pretreatment). The data
shown here are from one representative of three independent experiments. Boxed bands are from a longer exposure. M, mock; N/A, not applicable. *Non-speciﬁc band.
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These in vitro-generated HPV virions may not perfectly resemble
authentic virions isolated from HPV-infected tissues.
Mechanistically, autophagy inhibition by 3-MA in primary ker-
atinocytes delayed HPV16 capsid protein degradation during entry
(Fig. 6C). However, degradation of capsid proteins was not comple-
tely blocked by 3-MA. This could be due to the fact that 3-MA
treatment did not completely inhibit autophagy, as we observed
30% decrease in LC3-II turnover by 3-MA treatment (Fig. 3B),
consistent with previous ﬁndings (Fuertes et al., 2003; Zhou et al.,
2010). Another explanation for partial inhibition of capsid degrada-
tion by 3-MA is that there may be alternative routes for HPV16
trafﬁcking in the host cytoplasm other than autophagosomes. We
speculate that inhibition of autophagosome formation redirects
HPV16 virions to these alternative trafﬁcking routes, which could
represent productive pathways for HPV16 infection. Further studies
will be necessary to elucidate these alternative trafﬁcking routes and
assess their role in productive HPV16 infection.
Autophagy originally was regarded as a mechanism to maintain
cell homeostasis by removing damaged organelles and recycling
nutrients (Levine and Kroemer, 2008). It is now well accepted that
autophagy also plays an essential role in host defense by efﬁciently
degrading intracellular pathogens (Kudchodkar and Levine, 2009).
For example, the function of the autophagy gene Atg5 is critical for
protection against lethal Sindbis virus (SIN) infection of the mouse
central nervous system (Orvedahl et al., 2010). The p62 adapter
protein interacts with the SIN capsid protein to target the virus to
autophagosomes for degradation of viral proteins (Orvedahl et al.,
2010). While autophagy plays a critical role in host defense against
several viruses, autophagosomes can also provide a beneﬁcial
environment for replication of other viruses such as inﬂuenza virus
(Kudchodkar and Levine, 2009). Here, we report that autophagy is
induced by HPV16-infection and that this cellular response func-
tions as a host defense mechanism that limits the efﬁciency of HPV
infection of the natural host cell for this virus, human
keratinocytes.
As a housekeeping pathway, autophagy can be induced by
many cellular stresses, such as nutrient deprivation and hypoxia(He and Klionsky, 2009). However, as a host defense mechanism,
autophagy can be induced by pathogen-associated molecular
patterns (PAMPs) and their cognate pattern recognition receptors
(PRRs) such as toll-like receptors (Delgado et al., 2009; Delgado
and Deretic, 2009). Autophagy induced by PRRs has been shown
to directly eliminate intracellular pathogens, such as mycobacter-
ium (Delgado et al., 2008). Based on our ﬁndings that autophagy
is induced by HPV16 to inhibit infection, we speculate that HPV16
virions are recognized by certain PRRs in primary keratinocytes,
which trigger activation of innate immune signaling leading to
autophagy induction. Further studies will be necessary to under-
stand the mechanism(s) of innate immune activation and autop-
hagy induction by HPV16 in primary keratinocytes.Materials and methods
Reagents
3-methyladenine (3-MA) was purchased from Fisher (Acros,
New Jersey, US) and was dissolved in the appropriate cell culture
medium. E64d and Pepstatin A were purchased from Enzo Life
Sciences (Ann Arbor, MI) and were dissolved in DMSO. Furin was
purchased from New England BioLabs (Ipswich, MA).
Cell lines
293FT cells were purchased from Invitrogen (Grand Island, NY)
and maintained in Dulbecco’s modiﬁed eagle’s medium (DMEM)
(Thermo Scientiﬁc/HyClone, Logan, UT) supplemented with 10%
fetal bovine serum (FBS) (HyClone). HaCaT and NIKS cells were
obtained from Dr. Paul Lambert (University of Wisconsin-Madi-
son) and were cultured in E-medium (3 parts DMEM, 1 part Ham’s
F-12 nutrient mixture) supplemented with 5% FBS. NIKS cells
were co-cultured with mitomycin C-treated NIH 3T3 cells in
E-medium supplemented with 2.5% FBS, 0.4 mg/mL hydrocortisone,
8.4 ng/mL cholera toxin, 5 mg/mL insulin, 24 mg/mL adenine, and
10 ng/mL epidermal growth factor, as previously described
L.M. Grifﬁn et al. / Virology 437 (2013) 12–1918(Allen-Hoffmann et al., 2000). Mitomycin C-treated NIH-3T3 cells
were present throughout all experiments with NIKS cells, as no
difference in infectivity or autophagy was observed between NIKS
cells cultured alone and NIKS cells co-cultured with 3T3s (data
not shown). HFKs, derived from 3 neonatal foreskin donors, were
purchased from Invitrogen (Cascade Biologics, Portland, OR) and
cultured in EpiLife medium with 60 mM calcium supplemented
with human keratinocyte growth supplement (Invitrogen/Cas-
cade Biologics) according to the manufacturer’s protocol.
Production of HPV16 virions and pseudovirions
HPV16 virions and pseudovirions were prepared as described
previously (Buck et al., 2004, 2005; Pyeon et al., 2005). Brieﬂy,
293FT cells were cotransfected with a plasmid expressing HPV16
capsid proteins (p16SheLL) and either the full-length W12
genome (Flores et al., 1999) for HPV16-W12 virion production
or pLucF (Johnson et al., 2009) for HPV16-LucF pseudovirion
production. Plasmid constructs p16SheLL and pLucF were kindly
provided by Dr. John Schiller (National Cancer Institute).
Production of lentiviruses
Lentiviruses were prepared by cotransfecting packaging
plasmids pVSV-g (Dr. Jerome Schaack, University of Colorado
School of Medicine), pCMV-HIVdeltaR8.2 (Addgene, #12263),
adapted from an established protocol (Chen and Okayama, 1987).
The GFP-LC3 expression plasmid pCDH-GFP-LC3, was generated by
subcloning the GFP-LC3 gene from the pEGFP-C3 vector backbone
(Addgene plasmid #11546) into the pCDH-puro lentivirus expres-
sion vector (Dr. Jerome Schaack). shRNA expression plasmids,
shR-PIK3C3 (TRCN0000196290), ATG7 (TRCN0000007587), and
shR-ctrl plasmid (shc002), were obtained from Sigma-Aldrich
(The RNAi Consortium, Cambridge, MA), through the Functional
Genomics Facility at the University of Colorado Boulder.
Infectivity assays
To measure HPV infectivity, cells were inoculated with
10,000 vge/cell HPV16-LucF and luciferase activity was measured
at 48 hpi, using the Bright-GloTM Luciferase Assay System (Promega,
Madison, WI) according to the manufacturer’s instructions.
A virus concentration of 10,000 vge/cell HPV16-LucF was used
to allow for easy detection of infected cells across all cell lines
tested. In a parallel experiment, relative cell viability was mea-
sured using CellTiter-Glos Luminescent Cell Viability Assay
(Promega) according to the manufacturer’s instructions. Lumines-
cence was measured with a GloMaxs-Multiþ Detection System
with InstinctTM software (Promega).
Immunoblotting
Cell lysates were prepared using a 1% SDS/PBS lysis buffer
containing cOmplete EDTA-free Mini Protease Inhibitor Cocktail
(Roche) and boiling for 10 min to ensure complete dissociation of
membrane bound LC3-II. QIAshredder homogenizer columns
(Qiagen, Valencia, CA) were used to reduce viscosity. Total protein
concentration was determined using the Pierces BCA Protein
Assay Kit (Thermo Scientiﬁc/Pierce Biotechnology, Rockford, IL)
and 20–40 mg total protein was used for immunoblotting. Anti-
bodies: mouse monoclonal anti-b-actin (1:5000, Cell Signaling
Technology, Danvers, MA), rabbit polyclonal anti-LC3B (1:1000,
Cell Signaling Technology), rabbit polyclonal anti-ATG7 (1:1000,
ProSci, San Diego, CA), rabbit polyclonal anti-VPS34 to detect
PIK3C3 (1:500, Life Technologies, Grand Island, NY), mouse
monoclonal anti-L1 (1:1000, CAMVIR-1, Abcam, Cambridge, MA)and HRP-conjugated secondary antibodies (1:10,000, Jackson
ImmunoResearch Laboratories, West Grove, PA). Proteins were
visualized using SuperSignals West Pico Chemiluminescent
Substrate (Thermo Scientiﬁc/Pierce Biotechnology) and the
ChemiDocTM XRSþSystem (Bio-Rad, Hercules, CA).
Confocal microscopy
HFKs were transduced with GFP-LC3 expressing lentiviruses
for 48 h prior to indicated treatments. Cells were ﬁxed with
4% paraformaldehyde and mounted with ProLongs Gold Antifade
Reagent with DAPI (Life Technologies). Imaging analysis was
performed on an Olympus FluoViews FV1000 confocal microscope
at the Advanced Light Microscopy Core Facility at the University
of Colorado School of Medicine.Acknowledgments
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